Clinical features of canine granulocytic anaplasmosis in 18 naturally infected dogs

Journal of Veterinary Internal Medicine

Volumn 22, Issue 6, 2008, Pages 1289-1295

  Kohn, Barbara ^a   Galke, D ^a   Beelitz, P ^b   Pfister, K ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anaplasma phagocytophilum; Canine tick borne disease; Immune mediated thrombocytopenia; Ixodes ricinus

Indexed keywords

ANTIINFECTIVE AGENT; DOXYCYCLINE;

ANAPLASMOSIS; ANIMAL; ARTICLE; DOG; DOG DISEASE; PATHOLOGY;

ANAPLASMOSIS; ANIMALS; ANTI-BACTERIAL AGENTS; DOG DISEASES; DOGS; DOXYCYCLINE;

ANAPLASMA PHAGOCYTOPHILUM; ANIMALIA; CANIS FAMILIARIS; IXODES RICINUS; IXODIDA; NEGIBACTERIA;

EID: 57149085705     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2008.0180.x     Document Type: Article

References (47)

1. Dumler JS, Barbet AF, Bekker CP, et al. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: Unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and "HGE agent" as subjective synonyms of Ehrlichia phagocytophila. Int J Syst Evol Microbiol 2001;51:2145-2165.
2. Blanco JR, Oteo JA. Human granulocytic ehrlichiosis in Europe. Clin Microbiol Infect 2002;8:763-772.
3. Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis 2000;31:554-560.
4. Horowitz HW, Kilchevsky E, Haber S, et al. Perinatal transmission of the agent of human granulocytic ehrlichiosis. N Engl J Med 1998;339:375-378.
5. Pusterla N, Braun U, Wolfensberger C, et al. Intrauterine infection with Ehrlichia phagocytophila in a cow. Vet Rec 1997;141:101-102.
6. Egenvall A, Bjöersdorff A, Lilliehöök I, et al. Early manifestations of granulocytic ehrlichiosis in dogs inoculated experimentally with a Swedish Ehrlichia species isolate. Vet Rec 1998;143:412-417.
7. Parola P, Davoust B, Raoult D. Tick- and flea-borne rickettsial emerging zoonoses. Vet Res 2005;36:469-492.
8. Katavolos P, Armstrong PM, Dawson JE, et al. Duration of tick attachment required for transmission of granulocytic ehrlichiosis. J Infect Dis 1998;177:1422-1425.
9. des Vignes F, Piesman J, Heffernan R, et al. Effect of tick removal on transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis nymphs. J Infect Dis 2001;183:773-778.
10. Bjöersdorff A. Ehrlichiosis and Anaplasmosis, Part 2: Anaplasma phagocytophilum comb. nov. infection. In: Shaw S, Day M, eds. Arthropod-Borne Infectious Diseases of the Dog and Cat. London: Manson Publishing; 2005:120-133.
11. Greig B, Armstrong PJ. Canine granulocytotropic anaplasmosis (A. phagocytophilum infection). In: Greene CE, ed. Infectious Diseases of the Dog and Cat. St Louis, MO: Elsevier Saunders; 2006:219-224.
12. Popov VL, Han VC, Chen SM, et al. Ultrastructural differentiation of the genogroups in the genus Ehrlichia. J Med Microbiol 1998;47:235-251.
13. Dumler JS, Choi KS, Garcia-Garcia JC, et al. Human granulocytic anaplasmosis and Anaplasma phagocytophilum. Emerg Infect Dis 2005;11:1828-1834.
14. Lilliehöök I, Egenvall A, Tvedten HW. Hematopathology in dogs experimentally infected with a Swedish granulocytic Ehrlichia species. Vet Clin Pathol 1998;27:116-122.
15. Egenvall A, Lilliehöök I, Bjöersdorff A, et al. Detection of granulocytic Ehrlichia species DNA by PCR in persistently infected dogs. Vet Rec 2000;146:186-190.
16. Maretzki CH, Fisher DJ, Greene CE. Granulocytic ehrlichiosis and meningitis in a dog. J Am Vet Med Assoc 1994;205:1554-1556.
17. Madewell BR, Gribble DH. Infection in two dogs with an agent resembling Ehrlichia equi. J Am Vet Med Assoc 1982;180:512-514.
18. Arsenault WG, Messick JB. Acute granulocytic ehrlichiosis in a rottweiler. J Am Anim Hosp Assoc 2005;41:323-326.
19. Bexfield NH, Villiers EJ, Herrtage ME. Immune-mediated haemolytic anaemia and thrombocytopenia associated with Anaplasma phagocytophilum in a dog. J Small Anim Pract 2005;46:543-548.
20. Kirtz G, Meli M, Leidinger E, et al. Anaplasma phagocytophilum infection in a dog: Identifying the causative agent using PCR. J Small Anim Pract 2005;46:300-303.
21. Lester SJ, Breitschwerdt EB, Collis CD, et al. Anaplasma phagocytophilum infection (granulocytic anaplasmosis) in a dog from Vancouver Island. Can Vet J 2005;46:825-827.
22. Pusterla N, Huder J, Wolfensberger C, et al. Granulocytic ehrlichiosis in two dogs in Switzerland. J Clin Microbiol 1997;35:2307-2309.
23. Kjelgaard-Hansen M, Jensen AL, Houser GA, et al. Use of serum C-reactive protein as an early marker of inflammatory activity in canine type II immune-mediated polyarthritis: Case report. Acta Vet Scand 2006;48:9.
24. Tarello W. Canine granulocytic ehrlichiosis (CGE) in Italy. Acta Vet Hung 2003;51:73-90.
25. Greig B, Asanovich KM, Armstrong PJ, et al. Geographic, clinical, serologic, and molecular evidence of granulocytic ehrlichiosis, a likely zoonotic disease, in Minnesota and Wisconsin dogs. J Clin Microbiol 1996;34:44-48.
26. Egenvall AE, Hedhammar AA, Bjöersdorff AI. Clinical features and serology of 14 dogs affected by granulocytic ehrlichiosis in Sweden. Vet Rec 1997;140:222-226.
27. Goldman EE, Breitschwerdt EB, Grindem CB, et al. Granulocytic ehrlichiosis in dogs from North Carolina and Virginia. J Vet Intern Med 1998;12:61-70.
28. Poitout FM, Shinozaki JK, Stockwell PJ, et al. Genetic variants of Anaplasma phagocytophilum infecting dogs in Western Washington State. J Clin Microbiol 2005;43:796-801.
29. Engelbrecht R, Kohn B, Leibold W, et al. Clinical findings, diagnostics and treatment results in primary and secondary immune-mediated hemolytic anemia in dog. Kleintierpraxis 2002;47:265-277.
30. Kohn B, Engelbrecht R, Leibold W, et al. Clinical findings, diagnostics, and treatment results in primary and secondary immune-mediated thrombocytopenia in the dog. Kleintierpraxis 2000;45:893-907.
31. Kohn B, Lübke S, Schmidt FG, et al. Idiopathic immune-mediated polyarthritis type I in dog: Occurence, clinical findings, laboratory results, therapy, and outcome of 16 cases (1996-2000). Kleintierpraxis 2005;50:415-428.
32. Courtney JW, Kostelnik LM, Zeidner NS, et al. Multiplex real-time PCR for detection of Anaplasma phagocytophilum and Borrelia burgdorferi. J Clin Microbiol 2004;42:3164-3168.
33. Beelitz P, Pfister K. Diagnostik und Therapie von Reisekrankheiten beim Hund. Tierarztl Prax 2004;32:158-165.
34. Jensen WA, Fall MZ, Rooney J, et al. Rapid identification and differentiation of Bartonella species using a single-step PCR assay. J Clin Microbiol 2000;38:1717-1722.
35. Hartelt K, Oehme R, Frank H, et al. Pathogens and symbionts in ticks: Prevalence of Anaplasma phagocytophilum (Ehrlichia sp.), Wolbachia sp., Rickettsia sp., and Babesia sp. in Southern Germany. Int JMed Microbiol 2004;293(Suppl 37):86-92.
36. von Loewenich FD, Baumgarten BU, Schroppel K, et al. High diversity of ankA sequences of Anaplasma phagocytophilum among Ixodes ricinus ticks in Germany. J Clin Microbiol 2003;41:5033-5040.
37. Hildebrandt A, Schmidt KH, Fingerle V, et al. Prevalence of granulocytic Ehrlichiae in Ixodes ricinus ticks in Middle Germany (Thuringia) detected by PCR and sequencing of a 16S ribosomal DNA fragment. FEMS Microbiol Lett 2002;211:225-230.
38. Barutzki D, De Nicola A, Zeziola M, et al. Seroprevalence of Anaplasma phagocytophilum infection in dogs in Germany. Berl Münch Tierärztl Wochenschr 2006;119:342-347.
39. Jensen J, Simon D, Escobar HM, et al. Anaplasma phagocytophilum in dogs in Germany. Zoonoses Public Health 2007;54:94-101.
40. Woody BJ, Hoskins JD. Ehrlichial diseases of dogs. Vet Clin North Am Small Anim Pract 1991;21:75-98.
41. Neer TM, Breitschwerdt EB, Greene RT, et al. Consensus statement on ehrlichial disease of small animals from the infectious disease study group of the ACVIM. American College of Veterinary Internal Medicine. J Vet Intern Med 2002;16:309-315.
42. Waner T, Harrus S, Weiss DJ, et al. Demonstration of serum antiplatelet antibodies in experimental acute canine ehrlichiosis. Vet Immunol Immunopathol 1995;48:177-182.
43. Wong SJ, Thomas JA. Cytoplasmic, nuclear, and platelet autoantibodies in human granulocytic ehrlichiosis patients. J Clin Microbiol 1998;36:1959-1963.
44. Smith RD, Ristic M, Huxsoll DL, et al. Platelet kinetics in canine ehrlichiosis: Evidence for increased platelet destruction as the cause of thrombocytopenia. Infect Immun 1975;11:1216-1221.
45. Eckersall P. Acute phase proteins as markers of inflammatory lesions. Comp Hematol Int 1995;5:93-97.
46. Matthewman LA, Kelly PJ, Brouqui P, et al. Further evidence for the efficacy of imidocarb dipropionate in the treatment of Ehrlichia canis infection. J S Afr Vet Assoc 1994;65:104-107.
47. Eddlestone SM, Neer TM, Gaunt SD, et al. Failure of imidocarb dipropionate to clear experimentally induced Ehrlichia canis infection in dogs. J Vet Intern Med 2006;20:840-844.